NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

This public procurement record has 1 release in its history.

Tender

20 Oct 2023 at 01:00

Summary of the contracting process

The public procurement contracting process is led by The Common Services Agency (NHS National Services Scotland) in Edinburgh, UK. The tender titled "NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab" falls under the "Health" industry category. The procurement method is an open procedure with an estimated value of 92,000,000 GBP. The tender deadline for submission is November 21, 2023. The tender aims to supply adalimumab, tocilizumab, and eculizumab to NHS Scotland.

This tender presents significant business growth opportunities for suppliers of medical supplies within the health industry. Companies capable of providing high-quality pharmaceutical products in compliance with regulatory standards are well-suited to compete. The tender's focus on multiple product lines and potential framework participation allows for a diverse range of businesses to engage and potentially secure long-term contracts for the supply of crucial medicines to NHS Scotland.

How relevant is this notice?

Notice Title

NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab

Notice Description

Supply of adalimumab, tocilizumab and eculizumab to NHS Scotland.

Lot Information

NP47923c Eculizumab

Supply of eculizumab vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the maximum 24 months. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

NP47923b Tocilizumab

Supply of tocilizumab pre-filled pens/devices, pre-filled syringes and vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 12 months, with an expiry date of 28 February 2025. This Lot has the option to extend by any number of periods, up to the maximum 36 months. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

NP47923a Adalimumab

Supply of Adalimumab pre-filled pens/devices and pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of six (6) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the maximum 24 months. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000747438
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT490936
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
OJEU - F2 - Contract Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£92,000,000 £10M-£100M
Lots Value
£94,015,132 £10M-£100M
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
20 Oct 20232 years ago
Submission Deadline
21 Nov 2023Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...